Iron Mountain Inc REIT/ US46284V1017 /
5/30/2024 10:10:00 PM | Chg. +1.26 | Volume | Bid1:33:46 PM | Ask1:33:46 PM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
79.64USD | +1.61% | 1.06 mill. Turnover: 54.95 mill. |
78.15Bid Size: 200 | 81.25Ask Size: 100 | 46.42 bill.USD | 3.11% | 126.41 |
GlobeNewswire
2:05 PM
Autonomix Medical, Inc. Reports Full Year 2024 Financial Results and Provides Corporate Update
GlobeNewswire
2:00 PM
Haoxi Health Technology Limited Reports Unaudited Financial Results for The Six Months Ended Decembe...
GlobeNewswire
2:00 PM
Generation Lab Introduces First Platform that Measures Aging & Treatment Efficacy to Help Extend the...
GlobeNewswire
2:00 PM
Autolus Therapeutics presents longer-term follow-up and additional data analysis of Pivotal Phase 2 ...
GlobeNewswire
2:00 PM
Lipella Pharmaceuticals Announces Completion of Site Initiation Visit for Phase 2a Trial of LP-310 i...
GlobeNewswire
2:00 PM
Milestone® Pharmaceuticals to Participate in the Upcoming Jefferies Global Healthcare Conference
GlobeNewswire
2:00 PM
Aptose Announces $4.43 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
GlobeNewswire
2:00 PM
PodcastOne (Nasdaq: PODC) Appoints Wall Street Veteran Jon Merriman to Its Board of Directors
GlobeNewswire
2:00 PM
ABM Named Among Barron’s 100 Most Sustainable Companies for Second Consecutive Year
GlobeNewswire
2:00 PM
Iterum Therapeutics Receives FDA Acceptance of Resubmission of NDA for Oral Sulopenem for the treatm...
GlobeNewswire
2:00 PM
SOND INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Sonder Holdings Inc. Investors...
GlobeNewswire
1:30 PM
Adaptive Biotechnologies Announces Data Supporting the Clinical Benefits of MRD Assessment with clon...